Holen Sie sich die Stockscreener-App
1.07
0.46%
-0.01
Finanzdaten der Atossa Therapeutics Inc-Aktie (ATOS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
21.93%
9.04
|
7.414 | 7.151 | 6.385 | 7.105 |
| Operating Income/Loss |
21.93%
-9.04
|
-7.414 | -7.151 | -6.385 | -7.105 |
| Income/Loss From Continuing Operations Before Tax |
25.38%
-8.423
|
-6.718 | -6.347 | -7.23 | -6.049 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
25.38%
-8.423
|
-6.718 | -6.347 | -7.23 | -6.049 |
|
Net Income/Loss
|
25.38%
-8.423
|
-6.718 | -6.347 | -7.23 | -6.049 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.00%
129.17
|
129.17 | 0.2505 | 125.77 | 125.73 |
| Diluted Average Shares |
0.00%
129.17
|
129.17 | 0.2505 | 125.77 | 125.73 |
| Basic Earnings Per Share |
40.00%
-0.07
|
-0.05 | -0.05 | -0.06 | -0.05 |
| Diluted Earnings Per Share |
40.00%
-0.07
|
-0.05 | -0.05 | -0.06 | -0.05 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.21%
2.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):